A patient is admitted to the emergency department in shock. Isoproterenol (Isuprel) is admitted. What would the nurse expect the effect of this drug would be?

A) Decrease in heart rate and perfusion, and an increase in inflammatory response: These manifestations suggest parasympathetic nervous system activation, not the sympathetic response. The sympathetic system generally increases heart rate and perfusion to support "fight or flight" responses. Additionally, inflammatory responses are more immune-related and are not a direct effect of sympathetic activation.

B) Increase motility and secretion in the GI tract, constriction of bronchi and pupils: This is characteristic of parasympathetic nervous system activity. The parasympathetic system stimulates digestion (increased motility and secretion) and causes bronchoconstriction and pupil constriction (miosis). The sympathetic nervous system, in contrast, inhibits GI motility and causes bronchodilation and pupil dilation.

C) Increase in blood pressure, bronchodilation, and decrease bowel sounds: These are hallmark signs of sympathetic nervous system activation. When the sympathetic system is activated during stress or danger, it leads to vasoconstriction, which increases blood pressure. Bronchodilation occurs to allow more oxygen intake, and GI motility decreases (manifested as reduced bowel sounds) to redirect energy to more vital functions, like increased circulation to muscles.

D) Decrease in sweating, decrease in respiration, and pupil constriction: These signs suggest parasympathetic or a relaxed state. The sympathetic nervous system typically increases sweating, respiration, and causes pupil dilation to prepare the body for increased activity. Decreased sweating and respiration, along with pupil constriction, would not be consistent with the sympathetic response.

A) Interferon-B (IFN-B): Interferon-beta is a disease-modifying therapy (DMT) used for multiple sclerosis (MS) to reduce the frequency and severity of attacks and slow disease progression. However, it is not typically used during an acute exacerbation of MS. It is more commonly prescribed for long-term management of the disease.
B) Mitoxantrone: Mitoxantrone is an immunosuppressive agent that is used as a disease-modifying therapy for patients with more aggressive forms of MS. While it can be helpful in reducing the frequency of attacks, it is not the first-line treatment during an acute relapse. Mitoxantrone is often considered for long-term use when other therapies are not effective.
C) Glatiramer acetate (Copaxone): Glatiramer acetate is another disease-modifying therapy for MS. It works by altering the immune response to protect the myelin sheath. Like interferon-beta, it is used for long-term management, not for acute attacks. It is not typically used during an exacerbation of MS.
D) Methylprednisolone (Solu-Medrol): Methylprednisolone, a corticosteroid, is the standard treatment for acute exacerbations of multiple sclerosis. It works by reducing inflammation, which helps to decrease the severity of symptoms during an MS relapse. The nurse would anticipate this drug being prescribed to manage the acute inflammatory episode and speed recovery from the attack. This medication is often administered intravenously in high doses and then tapered as the patient stabilizes.